What are the recommended induction medications and dosing for an adult female undergoing robot-assisted abdominal hysterectomy?

Anesthesia Induction Medications for Robot-Assisted Abdominal Hysterectomy

Use propofol (adequate dosing to avoid awareness) for induction combined with rocuronium (1.0-1.2 mg/kg) for neuromuscular blockade, with sugammadex immediately available for reversal if needed.

Induction Agent Selection

Propofol is the preferred induction agent for robot-assisted abdominal hysterectomy based on current evidence 1, 2. The 2015 Obstetric Anaesthetists' Association and Difficult Airway Society guidelines explicitly recommend propofol over thiopental for several compelling reasons: greater familiarity among practitioners, reliable supply, ease of preparation, fewer medication errors, and superior suppression of airway reflexes 2. This last property is particularly advantageous if intubation difficulties arise.

Critical Dosing Considerations

• Ensure adequate dosing to prevent awareness under general anesthesia, which has been documented as a significant problem in gynecologic surgery 2
• Have additional doses immediately available should airway management become prolonged 2
• Be prepared for potential hemodynamic instability (hypotension, myocardial depression) regardless of induction agent choice 1
• Consider fluid preloading and having vasopressors drawn up before induction

Alternative Considerations

Etomidate may be considered in hemodynamically unstable patients as it has minimal cardiovascular effects 3. However, be aware it causes transient adrenocortical suppression lasting 8-22 hours post-infusion 4, though this typically has no clinical sequelae in otherwise healthy patients.

Avoid ketamine as a primary induction agent in this setting—it increases upper airway secretions and may cause problematic interactions in certain scenarios 3.

Neuromuscular Blockade

Rocuronium 1.0-1.2 mg/kg is the recommended neuromuscular blocking agent 2. The 2025 DAS guidelines emphasize that effective neuromuscular block is critical for successful tracheal intubation and improves conditions for facemask ventilation and supraglottic airway device placement if needed 1.

Rocuronium vs. Suxamethonium

While suxamethonium historically provided faster onset, rocuronium with sugammadex backup offers several advantages 2:

• Sugammadex (16 mg/kg) can fully reverse rocuronium within 3 minutes, compared to 9 minutes for spontaneous offset of suxamethonium
• Suxamethonium increases oxygen consumption through depolarization, potentially causing earlier desaturation 2
• Suxamethonium is associated with increased risk of postoperative pulmonary complications 1
• Hypoxia occurs before recovery of neuromuscular activity with suxamethonium 2

Essential Practice Points

• Pre-calculate and prepare sugammadex dose (16 mg/kg) before induction—have it immediately available for an assistant to draw up 2
• Use quantitative neuromuscular monitoring to confirm adequate block before intubation attempts 1
• Do not rely on sugammadex reversal as a rescue strategy in "cannot intubate, cannot oxygenate" scenarios—it is unreliable and potentially dangerous 1

Monitoring Requirements

Before induction, ensure 1:

• Audible SpO2 tones enabled
• Continuous waveform capnography ready and tested during pre-oxygenation
• Quantitative neuromuscular monitoring available
• Standard monitoring (pulse oximetry, non-invasive blood pressure, ECG, temperature)

Pre-Oxygenation

Maximize safety by targeting an end-tidal oxygen fraction (ETO2) during pre-oxygenation while simultaneously verifying that waveform capnography is functioning correctly 1.

Adjunctive Intraoperative Considerations

While not induction agents per se, consider for the overall anesthetic plan:

• Multimodal opioid-sparing analgesia with short-acting opioids combined with local/regional blocks 5
• Dexmedetomidine infusion (1 μg/kg loading, 0.5-0.6 μg/kg/h maintenance) can reduce postoperative opioid requirements by >90% and improve recovery quality 6, 7, 8
• Preemptive analgesia: Consider gabapentin, NSAIDs (indomethacin or meloxicam), or COX-2 inhibitors before induction to reduce postoperative pain and narcotic consumption 9

Common Pitfalls to Avoid

1. Underdosing propofol—this increases awareness risk in gynecologic surgery 2
2. Not having sugammadex immediately available when using rocuronium 2
3. Attempting sugammadex reversal during failed intubation—proceed directly to airway rescue maneuvers 1
4. Forgetting to enable audible SpO2 monitoring before induction 1
5. Not preparing for hemodynamic instability with propofol, especially in the steep Trendelenburg position required for robotic surgery